Skip to main content
SpringerLink
Log in

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson’s disease?

For

  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181–184.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 1999; 26:171–182.

    Article  CAS  PubMed  Google Scholar 

  3. Tatsch K. Imaging of the dopaminergic system in parkinsonism with SPECT. Nucl Med Commun 2001; 22:819–827.

    Article  CAS  PubMed  Google Scholar 

  4. Brücke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I. SPECT and PET imaging of the dopaminergic system in Parkinson’s disease. J Neurol 2000; 247 (Suppl 4):IV/2–IV/7.

    Google Scholar 

  5. Brooks DJ. Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease. J Neurol 2000; 247 (Suppl 2):II/11–II/18

    Google Scholar 

  6. Stoessl AJ. Neurochemical and neuroreceptor imaging with PET in Parkinson’s disease. Adv Neurol 2001; 86:215–223.

    CAS  PubMed  Google Scholar 

  7. Lee CS, Samii A, Sossi I, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease. Ann Neurol 2000; 47:493–503.

    Article  CAS  PubMed  Google Scholar 

  8. Frey KA, Koeppe RA, Kilbourn MR. Imaging the vesicular monoamine transporter. Adv Neurol 2001; 86:237–247.

    CAS  PubMed  Google Scholar 

  9. Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease. A randomized controlled trial. JAMA 2000; 284:1931–1938.

    Article  Google Scholar 

  10. Ishikawa T, Dhawan V, Kazumata K, et al. Comparative nigrostriatal dopaminergic imaging with iodine-123 ßCIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med 1996; 37:1760–1765.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Klaus Tatsch

Authors
  1. Klaus Tatsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus Tatsch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tatsch, K. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson’s disease?. Eur J Nucl Med 29, 711–714 (2002). https://doi.org/10.1007/s00259-002-0814-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-002-0814-5

Keywords

Search

Navigation